OneSource Specialty Pharma Limited (NSEI: ONESOURCE)
Health Care · Life Sciences Tools & Services · IN
Rs1,508.00
-5.90% today · -19.4% 1Y
OneSource Specialty Pharma Limited (NSEI: ONESOURCE) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.80B and employs 1,412 people.
Over the last twelve months the share price has lost 19.4%, trading between 1.06K and 1.93K.
Tweenvest scores OneSource Specialty Pharma Limited across four factors: quality 56/100, value 56/100. Its strongest factor is quality.
ONESOURCE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.80B
- Revenue (TTM)
- $163.23M
- P/E
- —
- EPS
- -4.05
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs1,925.00
- 52-week low
- Rs1,057.00
- Avg volume (3M)
- —
- Shares outstanding
- 114.65M
- Employees
- 1,412
- Next earnings
- —
About OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.
- ISIN
- INE013P01021
- Founded
- 2007
- Listed since
- Jan 24, 2025
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fortrea Holdings Inc.NasdaqGS: FTRE | $1.96B | $20.37 | -0.92% |
| SKAN Group AGSWX: SKAN | $1.91B | CHF70.30 | -0.99% |
| Suzhou Sepax Technologies Co., Ltd.SHSE: 688758 | $1.87B | CN¥30.13 | -7.29% |
| BioLife Solutions, Inc.NasdaqCM: BLFS | $1.82B | $38.61 | +3.51% |
| PolyPeptide Group AGSWX: PPGN | $1.76B | CHF43.90 | -0.45% |
| Personalis, Inc.NasdaqGM: PSNL | $1.71B | $16.06 | +0.37% |
| Azenta, Inc.NasdaqGS: AZTA | $1.57B | $36.00 | +0.31% |
| Syngene International LimitedNSEI: SYNGENE | $1.49B | Rs361.30 | -4.59% |
Figures last refreshed Oct 4, 2026.